Screening and Monitoring of Prediabetes

AACE recommends that individuals who meet any of the clinical risk criteria noted below should be screened for prediabetes or type 2 diabetes (T2D)1.

  • Age ≥45 years without other risk factors
  • CVD or family history of T2D
  • Overweight or obese
  • Sedentary lifestyle
  • Member of an at-risk racial or ethnic group:
    • Asian
    • African American
    • Hispanic
    • Native American (Alaska Natives and American Indians)
    • Pacific Islander
  • High-density lipoprotein cholesterol (HDL-C) <35 mg/dL (0.90 mmol/L) and/or a triglyceride level >250 mg/dL (2.82 mmol/L)
  • Impaired glucose tolerance (IGT), impaired fasting glucose (IFG), and/or metabolic syndrome
  • Polycystic ovary syndrome (PCOS), acanthosis nigricans, or nonalcoholic fatty liver disease (NAFLD)
  • Hypertension (blood pressure >140/90 mm Hg or on antihypertensive therapy)
  • History of gestational diabetes or delivery of a baby weighing more than 4 kg (9 lb)
  • Antipsychotic therapy for schizophrenia and/or severe bipolar disease
  • Chronic glucocorticoid exposure
  • Sleep disorders in the presence of glucose intolerance (A1C >5.7%, IGT, or IFG on previous testing), including obstructive sleep apnea (OSA), chronic sleep deprivation, and night-shift occupation
Download Slides (PDF)